If he could somehow target the mutant protein, Druker reasoned, he could shut down the cancer. He worked with chemists at ...

Ramy Farid; President, Chief Executive Officer, Director; Schrodinger Inc Geoffrey Porges; Chief Financial Officer, Executive Vice President; Schrodinger Inc Steve Dechert; Analyst; KeyBanc Capital ...

Schrodinger, Inc. (NASDAQ:SDGR) shares are trading higher on Tuesday. The company disclosed a research collaboration and ...

In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

Schrodinger (SDGR) today announced a research collaboration and license agreement with Novartis (NVS) to advance multiple development ...

THE Philippine Press Institute (PPI) has spearheaded a health reporting workshop to help local journalists gain a deeper ...

Under the terms of the agreement, Novartis will pay Schrödinger $150m upfront and Schrödinger will also be eligible to ...

Schrödinger Inc.’s stock soared 14% Tuesday to put in on track for its biggest one-day gain in a year, after the company said ...

Rigel Pharmaceuticals, Inc. , a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Dean Schorno, the company's chief financial officer, will ...

Cellares, the world's first Integrated Development and Manufacturing Organization (IDMO), and a leader in automated cell therapy manufacturing, has appointed Ossama Eissa, former executive at Novartis ...

Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the third quarter of 2024 and provided a business update. In a separate press release issued earlier ...